Xoma | XOMA - Capital Ordinário



Capital Ordinário Alterar Data
AbbVie USD 1.77B 608K 2026-06
Agenus USD 38.52M 3.2M 2026-03
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Ardelyx USD 249.15M 2.17M 2026-06
aTyr Pharma USD 63.76M 765K 2026-06
BioMarin Pharmaceutical USD 193.68M 141K 2026-09
Celldex Therapeutics USD 78.53M 34K 2026-09
Curis USD 2M 10.93M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Incyte USD 200.98M 1.03M 2026-06
MacroGenics USD 63.65M 86K 2026-06
Novartis USD 1.89B 12.09M 2026-09
Novartis USD 1.89B 19.47M 2026-09
Pfizer USD 5.7B 1000K 2026-09
Prothena USD 51.74M 1.33M 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03